COVID-19-neutralizing antibodies predict disease severity and survival - ScienceDirect
Prevalence of anti-hepatitis E virus IgG antibodies in sera from hemodialysis patients in Tripoli, Lebanon | PLOS ONE
Microorganisms | Free Full-Text | Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins | HTML
A systematic review of SARS-CoV-2 vaccine candidates | Signal Transduction and Targeted Therapy
HEV IgM Rapid Test CE - CTK Biotech
Nasal delivery of an IgM offers broad protection from SARS-CoV-2 variants | Nature
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
Pre-existing humoral immunity to human common cold coronaviruses negatively impacts the protective SARS-CoV-2 antibody response - ScienceDirect
A Hyper-IgM Syndrome Mutation in Activation-Induced Cytidine Deaminase Disrupts G-Quadruplex Binding and Genome-wide Chromatin Localization - ScienceDirect
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development | ACS Central Science
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
A human iPSC-array-based GWAS identifies a virus susceptibility locus in the NDUFA4 gene and functional variants - ScienceDirect
Declining prevalence of hepatitis A and silent circulation of hepatitis E virus infection in southeastern Brazil - International Journal of Infectious Diseases
Risk of COVID-19 in health-care workers in Denmark: an observational cohort study - The Lancet Infectious Diseases
Delayed production of neutralizing antibodies correlates with fatal COVID-19 | Nature Medicine
Microorganisms | Free Full-Text | Serological Hendra Virus Diagnostics Using an Indirect ELISA-Based DIVA Approach with Recombinant Hendra G and N Proteins | HTML
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet
JCM | September-1 2022 - Browse Articles
Hepatitis E virus infection | Nature Reviews Disease Primers
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum | Nature Immunology
Two mutations in the ORF1 of genotype 1 hepatitis E virus enhance virus replication and may associate with fulminant hepatic failure | PNAS
Protective humoral and cellular immune responses to SARS-CoV-2 persist up to 1 year after recovery | Nature Communications
